Degarelix

Category: Cancer

Degarelix Overview

Degarelix, sold under the brand name Firmagon among others, is a hormonal therapy used in the treatment of prostate cancer.[3][4] Testosterone is a male hormone that promotes growth of many prostate tumours and therefore reducing circulating testosterone to very low (castration) levels is often the treatment goal in the management of advanced prostate cancer. Degarelix has an immediate onset of action, binding to gonadotropin-releasing hormone (GnRH) receptors ...

Read more Degarelix Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Degarelix

Recent Degarelix Forums:

Be the first to start a discussion about this drug.

NDC Database Records for Degarelix: (4 results)

Sorted by National Drug Code

• 55566-8301 Firmagon 20 mg/ml Subcutaneous Powder, Metered by Ferring Pharmaceuticals Inc.
• 55566-8303 Firmagon Kit by Ferring Pharmaceuticals Inc.
• 55566-8401 Firmagon 40 mg/ml Subcutaneous Powder, Metered by Ferring Pharmaceuticals Inc.
• 55566-8403 Firmagon Kit by Ferring Pharmaceuticals Inc.

Related Degarelix Topics: